StockTipsArenaBeta

BUY Manipal Health Enterprises Limited — Avinash Gorakshakar

BUYManipal Health Enterprises Limited

byAvinash GorakshakarHorizon: 1 year5 Aug 2026via Business Today

Entry₹657.55Inferred
Target₹795.78
Total upside +21.02%
Stop lossNot given
CMP₹724.6Just now
Active+10.20%+9.82%upside left 10 mo left
Follow Avinash Gorakshakar for new callsGet alertsWatch MANIPALHOS for new buy/sell callsGet alertsSee 4 other Long-term calls on MANIPALHOSSee 140 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 2:17 pm IST
9 supporting3 neutral1 opposing
Supports the BUY call (9)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·24 Sept · yesterday

Manipal Hospitals has redeemed outstanding listed non-convertible debentures (NCDs) worth ₹5,310 crore using IPO proceeds. This move strengthens the company's balance sheet and improves financial leve

BSE · Company Update·18 Sept · 6d ago

(opens in new tab)

Manipal Health Enterprises shares gain nearly 3% even as analysts differ on growth vs valuations

NewsCnbc-Tv18·10 Sept · 2w ago

(opens in new tab)

Manipal Health mcap crosses ₹1 lakh crore; stock up 36% since listing

NewsCnbc-Tv18·28 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (3)

Broker’s Call: Manipal Health Enterprises (Buy)

NewsHbl·31 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.